Substances With Anabolic And Other Hormonal Effect

Original Language Title: látky s anabolickým a jiným hormonálním účinkem

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.
454/2009 Sb.


of 7 November. December 2009,

amending, for the purposes of the Criminal Code provides for what is considered to be a substance

having an anabolic and other hormonal effect and what is their greater

quantity, and what, for the purposes of the Criminal Code considers the method

in terms of increasing the oxygen transfer in the human organism and for other

method with the dopingovým effect

Modified: 2/2012 Sb.

Government orders under section 289 paragraph. 4 of law No. 40/2009 Coll., the criminal


§ 1

For substances with anabolic and other hormonal effect within the meaning of § 288

the Penal Code shall be regarded as substances which are listed in annex No. 1.

to this regulation.

§ 2

Larger amounts of the substances with anabolic and other hormonal effect

within the meaning of § 288 of the criminal code means more than one blister,

injection or similar usually indivisible medicine pack containing the following

substances or similar amounts of these substances in a special dopingovém

of the product.

§ 3

A method of increasing the oxygen transport in the body

and for the other methods with dopingovým effect within the meaning of section 288 of the criminal

code, consider the methods that are listed in annex 2 to this

of the regulation.

§ 4

This Regulation shall enter into force on 1 January 2000. January 1, 2010.

Prime Minister:

Ing. Fischer, CSc in r.

Minister of Justice:

JUDr. Kabelo in r.

Annex 1

Substances with anabolic and other hormonal effect



1. Anabolic Androgenic Steroids (AAS):

and) Exogenous AAS, including: 1-androstendiol

(5a-androst-1-en-3b, 17b-diol); 1-androstenedione

(5a-androst-1-Ene-3.17-Dione); bolandiol (19-norandrostendiol);

bolasteron; boldenone; boldion (androsta-1.4-diene-3.17-Dione);

calusteron; clostebol; danazol (17a-ethynyl-17b-hydroxyandrost-

4-eno [2,3-d] isoxazol); dehydrochlormetyltestosteron (4-chloro-

17B-hydroxy-17a-metylandrosta-1.4-dien-3-one); desoxymetyltestosteron

(17a-methyl-5a-androst-2-en-17b-ol); drostanolon; etylestrenol

(19-nor-17a-pregn-4-Ene-17-ol); fluoxymesterone; formebolon; furazabol

(17b-hydroxy-17a-methyl-5a-androstano [2,3-c]-furazan); gestrinon;

4-hydroxytestosteron (4, 17b-dihydroxyandrost-4-en-3-one); mestanolon;

mesterolone; metenolon; methandrostenolone

(17b-hydroxy-17a-metylandrosta-1.4-dien-3-one); metandriol; metasteron

(2a, 17a-dimethyl-5-androstane-3-one-17b-ol); metyldienolon

(17b-hydroxy-17a-metylestra-4.9-diene-3-one); methyl-1-testosterone

(17b-hydroxy-17a-methyl-5a-androst-1-en-3-one); metylnortestosteron

(17b-hydroxy-17a-metylestr-4-en-3-one); metyltrienolon

(17b-hydroxy-17a-4, metylestra-9,11-trien-3-one); metyltestosteron;

miboleron; nandrolone; 19-norandrostendion (estr-4-Ene-3.17-Dione);

norboleton; norclostebol; norethandrolone; oxabolon; oxandrolone;

oxymesteron; oxymetolon; prostanozol ([3,2-c] pyrazol-5-

etioallocholan-17b-tetrahydropyranol); quinbolon; stanozolol;

stenbolon; 1-testosterone (17b-hydroxy-5a-androst-1-en-3-one);

tetrahydrogestrinon (18a-homo-pregna-4, 9,11-trien-17b-ol-3-one);

trenbolone and other substances with a similar chemical structure or similar

biological effects.

b) Endogenous AAS:

Androstendiol (androst-5-en-3b, 17b-diol) androstenedione

(androst-4-Ene-3.17-Dione), prasteron (dehydroepiandrosterone DHEA),

dihydrotestosterone, testosterone, and the following metabolites and isomers:

5A-androstane-3a, 17a-diol

5A-androstane-3a, 17b-diol

5A-androstane-3b, 17a-diol

5A-androstane-3b, 17b-diol

androst-4-Ene-3a, 17a-diol

androst-4-Ene-3a, 17b-diol

androst-5-en-3b, 17a-diol

androst-5-en-3a, 17a-diol

androst-5-en-3a, 17b-diol

androst-5-en-3b, 17a-diol

4-androstendiol (androst-4-Ene-3b, 17b-diol)

5-androstenedione (androst-5-Ene-3.17-Dione)






and other substances with a similar chemical structure or similar

biological effects.


Other anabolic agents, including:

Clenbuterol, selective androgenových receptor modulators (SARM),

tibolone, zeranol, zilpaterol and other substances having a similar effect.



1. substances erythropoeisis stimulating (e.g. erythropoietin EPO, darbepoetin


2. Growth hormone (hGH), insulin like growth factors (e.g..

IGF-1), mechanical growth factor (MGF);

3. the gonadotropins (hCG); and the luteinizing hormone (LH)

4. Insulin;

5. Kortikotropiny;

and other substances with a similar chemical structure or similar

biological effects and their releasing factors.



1. Inhibitors of aromatáz, including:

Aminoglutethimid, anastrozole, exemestane, letrozole, formestan,

testolacton, but not limited to them.

2. selective estrogen receptor modulators (SERMS), including:

Raloxifene, tamoxifen, Toremifene, but not limited to them.

3. other estrogenic substances including:

Cyklofenil, fulvestrant, clomiphene

4. substances modifying myostatin functions including myostatin inhibitors.

Annex 2

Method with the dopingovým effect



1. Blood doping, including the use of autologous, homologous or heterologous

blood or red blood cells, and similar products, of any


2. Artificial increasing consumption, transport or delivery of oxygen, involving

genetically modified hemoglobinové products (e.g. blood substitutes based on the

hemoglobin, haemoglobin mikroenkapsulované), perfluorochemicals and

efaproxiral (RSR13) and other products with a similar effect.



1. Transfer of nucleic acids or their sequences with potential

to enhance athletic performance.

2. the use of normal or genetically modified cells with the potential to

to enhance athletic performance.

3. the use of substances that directly or indirectly affect the function known for its

the influence on the performance by modifying gene expression, such as receptor

Delta peroxizomovými proliferátory/Peroxisome activated By

The activated Receptor d (PPARd) agonists/(e.g. GW 1516) and Agonists

axis proteinkinasové AMP-activated in conjunction with the PPAR delta

/PPARdelta-AMP-activated protein kinase (AMPK) axis agonists/

(e.g. AICAR).

Related Laws